MaaT Pharma
MaaT Pharma, a clinical stage company, has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating a range of cancers and Graft-versus-Host-Disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into improving outcomes of immunotherapy in solid tumors, we have built a powerful discovery and analysis platform, GutPrint®, to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions.
Tech Stack (28 technologies)
Frequently Asked Questions
What technologies does MaaT Pharma use?+
MaaT Pharma uses 28 technologies including Axeptio, Contact Form 7, EWWW Image Optimizer.
What industry is MaaT Pharma in?+
MaaT Pharma operates in the Biotechnology industry.
Where is MaaT Pharma based?+
MaaT Pharma is headquartered in France.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026